Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Benzodiazepines | 40 | 2024 | 1101 | 3.180 |
Why?
|
Anti-Anxiety Agents | 23 | 2021 | 390 | 2.680 |
Why?
|
Psychopharmacology | 15 | 2018 | 143 | 2.590 |
Why?
|
Psychomotor Agitation | 11 | 2022 | 293 | 1.520 |
Why?
|
Psychotropic Drugs | 23 | 2018 | 894 | 1.490 |
Why?
|
Antidepressive Agents | 26 | 2015 | 2838 | 1.140 |
Why?
|
Antipsychotic Agents | 28 | 2013 | 3057 | 1.130 |
Why?
|
Depressive Disorder | 33 | 2007 | 3748 | 1.130 |
Why?
|
Amygdala | 5 | 2010 | 1315 | 0.940 |
Why?
|
Dementia | 12 | 2022 | 2518 | 0.850 |
Why?
|
Psychiatry | 10 | 2015 | 1695 | 0.830 |
Why?
|
Learning | 7 | 2020 | 1713 | 0.740 |
Why?
|
Anxiety Disorders | 11 | 2020 | 2690 | 0.740 |
Why?
|
Clozapine | 8 | 2005 | 498 | 0.670 |
Why?
|
Electroconvulsive Therapy | 11 | 2002 | 477 | 0.600 |
Why?
|
Prefrontal Cortex | 3 | 2020 | 2147 | 0.570 |
Why?
|
Alzheimer Disease | 5 | 2021 | 8037 | 0.520 |
Why?
|
Lithium Carbonate | 2 | 2007 | 184 | 0.510 |
Why?
|
Teaching | 5 | 2015 | 1174 | 0.510 |
Why?
|
Mental Disorders | 28 | 2018 | 6600 | 0.470 |
Why?
|
Neurons | 9 | 2020 | 9338 | 0.460 |
Why?
|
Panic Disorder | 6 | 2019 | 616 | 0.450 |
Why?
|
Homes for the Aged | 4 | 2013 | 260 | 0.450 |
Why?
|
Hospitals, Psychiatric | 5 | 2012 | 332 | 0.440 |
Why?
|
Substance Withdrawal Syndrome | 8 | 2007 | 632 | 0.420 |
Why?
|
Schizophrenia | 14 | 2007 | 6882 | 0.420 |
Why?
|
Substance-Related Disorders | 16 | 2021 | 4258 | 0.410 |
Why?
|
Paroxetine | 8 | 2002 | 182 | 0.410 |
Why?
|
Psychotic Disorders | 10 | 2013 | 3046 | 0.400 |
Why?
|
Haloperidol | 4 | 2005 | 397 | 0.400 |
Why?
|
Neurosciences | 2 | 2015 | 348 | 0.390 |
Why?
|
Macaca mulatta | 4 | 2020 | 2375 | 0.390 |
Why?
|
Drug Prescriptions | 5 | 2015 | 1637 | 0.370 |
Why?
|
Geriatrics | 4 | 2010 | 396 | 0.370 |
Why?
|
Emotions | 7 | 2010 | 2661 | 0.370 |
Why?
|
Reward | 4 | 2010 | 941 | 0.360 |
Why?
|
Nursing Homes | 6 | 2013 | 1036 | 0.350 |
Why?
|
Fluoxetine | 6 | 1998 | 749 | 0.340 |
Why?
|
Mental Health Services | 2 | 2012 | 1643 | 0.340 |
Why?
|
Mental Processes | 1 | 2010 | 249 | 0.320 |
Why?
|
Schizophrenic Psychology | 6 | 2001 | 1678 | 0.320 |
Why?
|
Avoidance Learning | 1 | 2009 | 233 | 0.310 |
Why?
|
Aggression | 4 | 2008 | 753 | 0.310 |
Why?
|
Hippocampus | 1 | 2020 | 3675 | 0.310 |
Why?
|
Discrimination Learning | 1 | 2009 | 280 | 0.310 |
Why?
|
Judgment | 1 | 2010 | 281 | 0.310 |
Why?
|
Anticonvulsants | 5 | 2011 | 1916 | 0.300 |
Why?
|
Dibenzazepines | 3 | 1990 | 26 | 0.290 |
Why?
|
Humans | 175 | 2024 | 744343 | 0.280 |
Why?
|
Risperidone | 3 | 2005 | 383 | 0.280 |
Why?
|
Prosencephalon | 1 | 2008 | 303 | 0.280 |
Why?
|
Monoamine Oxidase Inhibitors | 7 | 1995 | 158 | 0.270 |
Why?
|
Cognition | 7 | 2010 | 6770 | 0.260 |
Why?
|
Lorazepam | 4 | 1991 | 145 | 0.260 |
Why?
|
Antidepressive Agents, Tricyclic | 9 | 2007 | 434 | 0.260 |
Why?
|
Education, Medical | 2 | 2014 | 1721 | 0.260 |
Why?
|
Depression | 17 | 2015 | 7766 | 0.250 |
Why?
|
Anxiety | 19 | 2022 | 4297 | 0.250 |
Why?
|
Primates | 1 | 2007 | 545 | 0.250 |
Why?
|
Models, Neurological | 4 | 2020 | 1774 | 0.240 |
Why?
|
Motivation | 3 | 2010 | 1971 | 0.240 |
Why?
|
Quinolones | 1 | 2007 | 367 | 0.230 |
Why?
|
Affect | 4 | 2010 | 1476 | 0.230 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2008 | 1004 | 0.220 |
Why?
|
Curriculum | 6 | 2014 | 3605 | 0.210 |
Why?
|
Basal Ganglia Diseases | 2 | 2001 | 149 | 0.210 |
Why?
|
Mentally Ill Persons | 2 | 1999 | 126 | 0.200 |
Why?
|
Prescriptions | 1 | 2024 | 387 | 0.200 |
Why?
|
Drug Utilization | 7 | 2013 | 1183 | 0.190 |
Why?
|
Clinical Trials as Topic | 14 | 2010 | 7913 | 0.190 |
Why?
|
Hypnotics and Sedatives | 3 | 2008 | 1162 | 0.190 |
Why?
|
Alcoholism | 2 | 2007 | 1906 | 0.190 |
Why?
|
Drug Therapy, Combination | 17 | 2007 | 6489 | 0.190 |
Why?
|
Aged | 60 | 2015 | 163280 | 0.190 |
Why?
|
Substance P | 1 | 2001 | 335 | 0.190 |
Why?
|
Psychiatric Status Rating Scales | 13 | 2007 | 6038 | 0.180 |
Why?
|
Community Mental Health Centers | 2 | 2011 | 102 | 0.180 |
Why?
|
Borderline Personality Disorder | 3 | 1996 | 736 | 0.180 |
Why?
|
Alprazolam | 1 | 1999 | 98 | 0.170 |
Why?
|
Hostility | 10 | 1977 | 189 | 0.170 |
Why?
|
Consensus | 1 | 2008 | 2959 | 0.170 |
Why?
|
S-Adenosylmethionine | 1 | 2000 | 212 | 0.170 |
Why?
|
Agoraphobia | 2 | 2003 | 179 | 0.160 |
Why?
|
Tranylcypromine | 1 | 1998 | 29 | 0.160 |
Why?
|
Human Experimentation | 1 | 1999 | 127 | 0.160 |
Why?
|
Behavior, Animal | 2 | 2020 | 1881 | 0.160 |
Why?
|
Lithium | 5 | 1995 | 601 | 0.150 |
Why?
|
Attention | 1 | 2008 | 2400 | 0.150 |
Why?
|
Object Attachment | 1 | 2020 | 313 | 0.150 |
Why?
|
Photic Stimulation | 3 | 2009 | 2025 | 0.150 |
Why?
|
Long-Term Care | 2 | 1999 | 607 | 0.150 |
Why?
|
Haplorhini | 2 | 2009 | 552 | 0.150 |
Why?
|
Bipolar Disorder | 5 | 2011 | 5027 | 0.140 |
Why?
|
1-Naphthylamine | 2 | 1996 | 49 | 0.140 |
Why?
|
Task Performance and Analysis | 2 | 2020 | 780 | 0.140 |
Why?
|
Practice Guidelines as Topic | 4 | 2013 | 7279 | 0.140 |
Why?
|
Piperazines | 1 | 2007 | 2488 | 0.140 |
Why?
|
Mother-Child Relations | 1 | 2020 | 481 | 0.140 |
Why?
|
Brain | 8 | 2010 | 26385 | 0.140 |
Why?
|
Receptors, Neurotransmitter | 2 | 1993 | 178 | 0.140 |
Why?
|
Phytotherapy | 1 | 1998 | 298 | 0.130 |
Why?
|
Health Policy | 1 | 2008 | 2661 | 0.130 |
Why?
|
Mianserin | 2 | 2007 | 52 | 0.130 |
Why?
|
Depression, Postpartum | 1 | 2020 | 340 | 0.130 |
Why?
|
Patient Compliance | 5 | 1995 | 2684 | 0.130 |
Why?
|
Psychotherapy | 5 | 2006 | 1643 | 0.130 |
Why?
|
Homovanillic Acid | 2 | 1993 | 75 | 0.130 |
Why?
|
Drug Interactions | 9 | 2008 | 1460 | 0.120 |
Why?
|
Plant Extracts | 1 | 1998 | 471 | 0.120 |
Why?
|
Child Abuse, Sexual | 2 | 1996 | 383 | 0.120 |
Why?
|
Parasympatholytics | 2 | 1991 | 91 | 0.120 |
Why?
|
Cognition Disorders | 3 | 2008 | 4043 | 0.120 |
Why?
|
Agranulocytosis | 2 | 1990 | 101 | 0.120 |
Why?
|
Advisory Committees | 1 | 2018 | 775 | 0.120 |
Why?
|
Anger | 3 | 1995 | 402 | 0.120 |
Why?
|
Oxazepam | 5 | 1983 | 6 | 0.110 |
Why?
|
Age Factors | 17 | 2010 | 18370 | 0.110 |
Why?
|
Drug Therapy | 3 | 1995 | 497 | 0.110 |
Why?
|
Legislation, Drug | 2 | 2006 | 206 | 0.110 |
Why?
|
Consensus Development Conferences as Topic | 2 | 2010 | 170 | 0.110 |
Why?
|
Isoxazoles | 1 | 1994 | 216 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1003 | 0.110 |
Why?
|
Valproic Acid | 1 | 1995 | 445 | 0.100 |
Why?
|
Pancreas | 1 | 1999 | 1686 | 0.100 |
Why?
|
Hyperparathyroidism | 1 | 1993 | 339 | 0.100 |
Why?
|
Comorbidity | 8 | 2008 | 10388 | 0.100 |
Why?
|
Fluvoxamine | 2 | 2001 | 74 | 0.100 |
Why?
|
Action Potentials | 2 | 2009 | 1806 | 0.100 |
Why?
|
Off-Label Use | 1 | 2013 | 169 | 0.100 |
Why?
|
Animals | 12 | 2020 | 168757 | 0.100 |
Why?
|
Education, Medical, Continuing | 2 | 2014 | 840 | 0.100 |
Why?
|
Medicaid | 5 | 2011 | 2736 | 0.100 |
Why?
|
Hypercalcemia | 1 | 1993 | 409 | 0.100 |
Why?
|
ROC Curve | 2 | 2009 | 3527 | 0.090 |
Why?
|
Diazepam | 3 | 1983 | 205 | 0.090 |
Why?
|
Suicide | 3 | 2010 | 1477 | 0.090 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2007 | 4266 | 0.090 |
Why?
|
Disulfiram | 1 | 1990 | 57 | 0.090 |
Why?
|
Appetitive Behavior | 1 | 2009 | 37 | 0.090 |
Why?
|
Reinforcement Schedule | 1 | 2009 | 129 | 0.090 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 950 | 0.090 |
Why?
|
Memory | 4 | 1988 | 2174 | 0.090 |
Why?
|
Chlordiazepoxide | 6 | 1977 | 42 | 0.080 |
Why?
|
Drug Administration Schedule | 8 | 2003 | 4933 | 0.080 |
Why?
|
Blinking | 1 | 2009 | 138 | 0.080 |
Why?
|
Group Processes | 5 | 1977 | 225 | 0.080 |
Why?
|
Bupropion | 3 | 1999 | 303 | 0.080 |
Why?
|
Mental Recall | 2 | 2001 | 1205 | 0.080 |
Why?
|
United States Food and Drug Administration | 3 | 2010 | 1584 | 0.080 |
Why?
|
Drug Labeling | 1 | 2010 | 233 | 0.080 |
Why?
|
Receptors, Melatonin | 1 | 2008 | 31 | 0.080 |
Why?
|
Akathisia, Drug-Induced | 2 | 1986 | 67 | 0.080 |
Why?
|
Conditioning, Operant | 1 | 2009 | 313 | 0.080 |
Why?
|
Combined Modality Therapy | 4 | 2008 | 8642 | 0.080 |
Why?
|
Physical Stimulation | 1 | 2009 | 525 | 0.080 |
Why?
|
Hospitalization | 4 | 2020 | 10262 | 0.080 |
Why?
|
GABA-A Receptor Agonists | 1 | 2008 | 84 | 0.080 |
Why?
|
Analgesics, Opioid | 1 | 2024 | 3674 | 0.080 |
Why?
|
Interinstitutional Relations | 1 | 1989 | 241 | 0.080 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2005 | 1953 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 2 | 2001 | 503 | 0.070 |
Why?
|
Internship and Residency | 6 | 2015 | 5788 | 0.070 |
Why?
|
Computer Simulation | 1 | 2020 | 6196 | 0.070 |
Why?
|
Depressive Disorder, Major | 3 | 2010 | 4644 | 0.070 |
Why?
|
Evidence-Based Practice | 2 | 2023 | 500 | 0.070 |
Why?
|
Conditioning, Classical | 1 | 2009 | 366 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2000 | 10943 | 0.070 |
Why?
|
Phobic Disorders | 3 | 2001 | 439 | 0.070 |
Why?
|
Public Health Administration | 1 | 1989 | 240 | 0.070 |
Why?
|
Attitude of Health Personnel | 4 | 2003 | 3843 | 0.070 |
Why?
|
Arousal | 2 | 2007 | 1165 | 0.070 |
Why?
|
Female | 45 | 2020 | 380194 | 0.070 |
Why?
|
Product Surveillance, Postmarketing | 1 | 1990 | 430 | 0.070 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2007 | 377 | 0.070 |
Why?
|
Dangerous Behavior | 1 | 1986 | 66 | 0.070 |
Why?
|
Male | 46 | 2020 | 350118 | 0.070 |
Why?
|
Piperidines | 1 | 1994 | 1602 | 0.070 |
Why?
|
Guideline Adherence | 3 | 2013 | 2266 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2014 | 1008 | 0.070 |
Why?
|
History, 21st Century | 1 | 2011 | 1534 | 0.070 |
Why?
|
Drug Discovery | 2 | 2010 | 1058 | 0.060 |
Why?
|
Cannabis | 5 | 1977 | 439 | 0.060 |
Why?
|
Brain Mapping | 1 | 2020 | 6669 | 0.060 |
Why?
|
Double-Blind Method | 7 | 2002 | 12026 | 0.060 |
Why?
|
Massachusetts | 4 | 2012 | 8663 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2019 | 9959 | 0.060 |
Why?
|
Tranquilizing Agents | 2 | 1978 | 59 | 0.060 |
Why?
|
Mesencephalon | 1 | 2005 | 329 | 0.060 |
Why?
|
History, 20th Century | 1 | 2011 | 2740 | 0.060 |
Why?
|
Time Factors | 5 | 2020 | 40075 | 0.060 |
Why?
|
Middle Aged | 29 | 2011 | 213383 | 0.060 |
Why?
|
Private Practice | 2 | 1982 | 154 | 0.060 |
Why?
|
Sertraline | 2 | 1996 | 206 | 0.060 |
Why?
|
Polysomnography | 2 | 2008 | 1776 | 0.060 |
Why?
|
Models, Animal | 1 | 2010 | 2171 | 0.060 |
Why?
|
Injections, Intramuscular | 3 | 1991 | 552 | 0.060 |
Why?
|
Ambulatory Care | 3 | 2001 | 2708 | 0.060 |
Why?
|
Adult | 36 | 2020 | 214055 | 0.060 |
Why?
|
Family Practice | 1 | 2006 | 516 | 0.050 |
Why?
|
Analysis of Variance | 4 | 2009 | 6365 | 0.050 |
Why?
|
Reaction Time | 1 | 2009 | 2097 | 0.050 |
Why?
|
Trazodone | 2 | 1993 | 66 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2014 | 2291 | 0.050 |
Why?
|
Seizures | 1 | 1995 | 2859 | 0.050 |
Why?
|
Dyskinesia, Drug-Induced | 2 | 1984 | 163 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 21746 | 0.050 |
Why?
|
United States | 14 | 2011 | 69872 | 0.050 |
Why?
|
Research | 5 | 2003 | 1999 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2008 | 12959 | 0.050 |
Why?
|
Melatonin | 1 | 2008 | 721 | 0.050 |
Why?
|
Behavior Therapy | 1 | 2008 | 865 | 0.050 |
Why?
|
Interview, Psychological | 3 | 1995 | 812 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 4 | 1988 | 1240 | 0.050 |
Why?
|
Personality Disorders | 1 | 2006 | 713 | 0.050 |
Why?
|
Fear | 1 | 2010 | 1440 | 0.050 |
Why?
|
Half-Life | 3 | 1991 | 661 | 0.050 |
Why?
|
Mood Disorders | 2 | 2003 | 1106 | 0.050 |
Why?
|
Cues | 1 | 2005 | 873 | 0.050 |
Why?
|
Quality of Life | 2 | 2015 | 12804 | 0.050 |
Why?
|
Therapeutic Equivalency | 1 | 2000 | 141 | 0.050 |
Why?
|
Dibenzothiazepines | 1 | 2000 | 103 | 0.050 |
Why?
|
Meta-Analysis as Topic | 3 | 2010 | 1344 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2007 | 63114 | 0.050 |
Why?
|
Dreams | 1 | 2001 | 147 | 0.040 |
Why?
|
Personality Inventory | 7 | 1993 | 1030 | 0.040 |
Why?
|
Treatment Failure | 1 | 2006 | 2618 | 0.040 |
Why?
|
Accidental Falls | 1 | 2008 | 1062 | 0.040 |
Why?
|
Biological Availability | 1 | 2000 | 397 | 0.040 |
Why?
|
Violence | 1 | 1986 | 909 | 0.040 |
Why?
|
Research Design | 2 | 2008 | 5987 | 0.040 |
Why?
|
New Jersey | 3 | 2004 | 290 | 0.040 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1901 | 0.040 |
Why?
|
Risk Assessment | 4 | 2013 | 23338 | 0.040 |
Why?
|
Pilot Projects | 2 | 2007 | 8324 | 0.040 |
Why?
|
Scientific Misconduct | 1 | 1999 | 71 | 0.040 |
Why?
|
Neural Pathways | 1 | 2009 | 2972 | 0.040 |
Why?
|
Cyclohexanols | 1 | 1999 | 127 | 0.040 |
Why?
|
Financing, Government | 1 | 1982 | 468 | 0.040 |
Why?
|
Dopamine | 1 | 2005 | 1591 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 1989 | 2759 | 0.040 |
Why?
|
Risk | 3 | 1999 | 9687 | 0.040 |
Why?
|
Hospitals, State | 2 | 1990 | 29 | 0.040 |
Why?
|
New York | 3 | 2006 | 886 | 0.040 |
Why?
|
Drug Evaluation | 4 | 1991 | 647 | 0.040 |
Why?
|
Community Mental Health Services | 3 | 1990 | 386 | 0.040 |
Why?
|
Receptors, GABA | 1 | 1999 | 288 | 0.040 |
Why?
|
Risk Factors | 5 | 2013 | 72290 | 0.040 |
Why?
|
Chronic Disease | 5 | 2001 | 9146 | 0.040 |
Why?
|
Placebos | 9 | 1998 | 1676 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.040 |
Why?
|
Self Concept | 4 | 1976 | 1025 | 0.040 |
Why?
|
Serotonin | 1 | 2001 | 1017 | 0.040 |
Why?
|
Patient Rights | 1 | 1977 | 126 | 0.040 |
Why?
|
Paranoid Disorders | 2 | 1987 | 60 | 0.040 |
Why?
|
Aged, 80 and over | 9 | 2007 | 57776 | 0.030 |
Why?
|
Decision Making | 1 | 2010 | 3887 | 0.030 |
Why?
|
Depression, Chemical | 1 | 1995 | 191 | 0.030 |
Why?
|
Nursing Assessment | 1 | 1995 | 107 | 0.030 |
Why?
|
Tablets | 2 | 2007 | 145 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2003 | 1411 | 0.030 |
Why?
|
Personality | 3 | 1975 | 552 | 0.030 |
Why?
|
Echothiophate Iodide | 1 | 1974 | 1 | 0.030 |
Why?
|
Thyroxine | 1 | 1998 | 667 | 0.030 |
Why?
|
Research Personnel | 1 | 1999 | 573 | 0.030 |
Why?
|
Carbamazepine | 1 | 1995 | 229 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2002 | 1372 | 0.030 |
Why?
|
Professional Practice | 1 | 1976 | 326 | 0.030 |
Why?
|
Frustration | 4 | 1977 | 22 | 0.030 |
Why?
|
Secobarbital | 1 | 1973 | 2 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2001 | 1738 | 0.030 |
Why?
|
Attitude to Health | 2 | 1995 | 2052 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2004 | 1622 | 0.030 |
Why?
|
Narcolepsy | 1 | 1976 | 195 | 0.030 |
Why?
|
Terminology as Topic | 2 | 2010 | 1547 | 0.030 |
Why?
|
Receptors, Serotonin | 1 | 1993 | 201 | 0.030 |
Why?
|
Apnea | 1 | 1974 | 195 | 0.030 |
Why?
|
Cholinesterase Inhibitors | 1 | 1974 | 238 | 0.030 |
Why?
|
Longitudinal Studies | 4 | 2003 | 13989 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4687 | 0.030 |
Why?
|
Hydrocortisone | 2 | 1993 | 1826 | 0.030 |
Why?
|
Ethics, Medical | 1 | 1977 | 792 | 0.030 |
Why?
|
Catecholamines | 1 | 1993 | 387 | 0.030 |
Why?
|
Electrocardiography | 1 | 1985 | 6442 | 0.030 |
Why?
|
Breast Feeding | 1 | 2020 | 1338 | 0.030 |
Why?
|
Rats | 1 | 2008 | 24260 | 0.030 |
Why?
|
Behavior | 2 | 1972 | 561 | 0.030 |
Why?
|
Metabolic Clearance Rate | 2 | 1982 | 380 | 0.030 |
Why?
|
Prolactin | 1 | 1993 | 669 | 0.020 |
Why?
|
Kinetics | 3 | 1985 | 6473 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2007 | 3610 | 0.020 |
Why?
|
Maine | 1 | 2011 | 139 | 0.020 |
Why?
|
Biotransformation | 2 | 1982 | 168 | 0.020 |
Why?
|
Psychoses, Substance-Induced | 1 | 1991 | 96 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 35421 | 0.020 |
Why?
|
Night Care | 1 | 1969 | 28 | 0.020 |
Why?
|
Adolescent | 8 | 2011 | 85781 | 0.020 |
Why?
|
Hallucinogens | 1 | 1972 | 180 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2005 | 5708 | 0.020 |
Why?
|
Receptors, GABA-A | 1 | 1993 | 627 | 0.020 |
Why?
|
Training Support | 2 | 1982 | 113 | 0.020 |
Why?
|
Memory Disorders | 3 | 1982 | 1184 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2008 | 25043 | 0.020 |
Why?
|
Sleep Stages | 2 | 2001 | 686 | 0.020 |
Why?
|
Methylphenidate | 1 | 1992 | 473 | 0.020 |
Why?
|
Cost Control | 1 | 1990 | 624 | 0.020 |
Why?
|
Sleep, REM | 2 | 2001 | 595 | 0.020 |
Why?
|
Child | 6 | 2010 | 77709 | 0.020 |
Why?
|
Collagen Diseases | 1 | 1967 | 34 | 0.020 |
Why?
|
Drug Approval | 1 | 1994 | 742 | 0.020 |
Why?
|
Geriatric Psychiatry | 1 | 2008 | 70 | 0.020 |
Why?
|
Administration, Oral | 2 | 2007 | 3913 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 1969 | 392 | 0.020 |
Why?
|
Drug Costs | 1 | 1995 | 1105 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1990 | 1588 | 0.020 |
Why?
|
Program Evaluation | 2 | 2006 | 2488 | 0.020 |
Why?
|
Acute Disease | 2 | 1991 | 7149 | 0.020 |
Why?
|
Verbal Behavior | 2 | 1977 | 339 | 0.020 |
Why?
|
Health Services | 1 | 2011 | 758 | 0.020 |
Why?
|
Sleep | 1 | 2001 | 4623 | 0.020 |
Why?
|
Malpractice | 1 | 1990 | 572 | 0.020 |
Why?
|
Child Psychiatry | 1 | 2008 | 220 | 0.020 |
Why?
|
Nadolol | 1 | 1984 | 30 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2003 | 5319 | 0.020 |
Why?
|
Hospitals, General | 2 | 1980 | 749 | 0.020 |
Why?
|
Causality | 1 | 1991 | 1275 | 0.020 |
Why?
|
MMPI | 3 | 1975 | 86 | 0.020 |
Why?
|
Drug Combinations | 1 | 1990 | 1959 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 1990 | 1681 | 0.020 |
Why?
|
Algorithms | 1 | 2005 | 13881 | 0.020 |
Why?
|
Child Abuse | 1 | 1993 | 1030 | 0.020 |
Why?
|
Hospitals, Proprietary | 1 | 1984 | 39 | 0.020 |
Why?
|
Glaucoma | 1 | 1974 | 1159 | 0.020 |
Why?
|
Propanolamines | 1 | 1984 | 167 | 0.010 |
Why?
|
Confusion | 1 | 1986 | 275 | 0.010 |
Why?
|
Communication | 2 | 1995 | 3749 | 0.010 |
Why?
|
Recurrence | 1 | 1995 | 8340 | 0.010 |
Why?
|
Reference Standards | 1 | 2007 | 1025 | 0.010 |
Why?
|
Patient Selection | 1 | 1995 | 4215 | 0.010 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1992 | 1444 | 0.010 |
Why?
|
California | 1 | 2007 | 1402 | 0.010 |
Why?
|
Propranolol | 1 | 1984 | 502 | 0.010 |
Why?
|
Hospitals, Public | 1 | 1984 | 207 | 0.010 |
Why?
|
Utilization Review | 1 | 1984 | 392 | 0.010 |
Why?
|
Social Behavior | 3 | 1974 | 1127 | 0.010 |
Why?
|
Fatigue | 2 | 1983 | 1531 | 0.010 |
Why?
|
Suicide, Attempted | 1 | 2010 | 1221 | 0.010 |
Why?
|
Psychological Tests | 3 | 1975 | 651 | 0.010 |
Why?
|
Prevalence | 2 | 1996 | 15226 | 0.010 |
Why?
|
Family | 1 | 1973 | 3147 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 1995 | 3022 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 1984 | 404 | 0.010 |
Why?
|
Intelligence Tests | 2 | 1973 | 505 | 0.010 |
Why?
|
Time | 1 | 2003 | 542 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 1995 | 3229 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 1996 | 15540 | 0.010 |
Why?
|
Psychometrics | 1 | 2010 | 3002 | 0.010 |
Why?
|
Medicare | 1 | 1999 | 6566 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1984 | 1144 | 0.010 |
Why?
|
Barbiturates | 1 | 1981 | 114 | 0.010 |
Why?
|
Thematic Apperception Test | 2 | 1977 | 39 | 0.010 |
Why?
|
Aging | 4 | 2003 | 8664 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6538 | 0.010 |
Why?
|
Amnesia | 1 | 1982 | 248 | 0.010 |
Why?
|
Cause of Death | 1 | 2010 | 3584 | 0.010 |
Why?
|
Periodicity | 1 | 2001 | 363 | 0.010 |
Why?
|
Eligibility Determination | 1 | 2003 | 403 | 0.010 |
Why?
|
Cerebrovascular Circulation | 2 | 1984 | 2731 | 0.010 |
Why?
|
Flurazepam | 1 | 1979 | 8 | 0.010 |
Why?
|
Faculty, Medical | 1 | 2008 | 1181 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2001 | 39050 | 0.010 |
Why?
|
Eyelids | 1 | 2001 | 265 | 0.010 |
Why?
|
Ferricyanides | 1 | 1978 | 32 | 0.010 |
Why?
|
Digitalis Glycosides | 1 | 1978 | 47 | 0.010 |
Why?
|
Societies, Medical | 1 | 1991 | 3743 | 0.010 |
Why?
|
Anemia, Pernicious | 1 | 1978 | 19 | 0.010 |
Why?
|
Nitroprusside | 1 | 1978 | 275 | 0.010 |
Why?
|
Parathyroid Diseases | 1 | 1978 | 48 | 0.010 |
Why?
|
Infant | 1 | 2020 | 35136 | 0.010 |
Why?
|
Dexamethasone | 1 | 1985 | 1951 | 0.010 |
Why?
|
Chlorpromazine | 1 | 1978 | 111 | 0.010 |
Why?
|
Cortisone | 1 | 1978 | 89 | 0.010 |
Why?
|
Hypochondriasis | 1 | 1978 | 92 | 0.010 |
Why?
|
Monitoring, Ambulatory | 1 | 2001 | 355 | 0.010 |
Why?
|
Paternalism | 1 | 1977 | 46 | 0.010 |
Why?
|
Defense Mechanisms | 1 | 1978 | 178 | 0.010 |
Why?
|
Jurisprudence | 1 | 1977 | 110 | 0.010 |
Why?
|
Antiparkinson Agents | 1 | 1978 | 184 | 0.010 |
Why?
|
Antiemetics | 1 | 1979 | 177 | 0.010 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 1998 | 187 | 0.010 |
Why?
|
Schizotypal Personality Disorder | 1 | 1978 | 288 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1989 | 3589 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2429 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2010 | 19905 | 0.010 |
Why?
|
Civil Rights | 1 | 1977 | 132 | 0.010 |
Why?
|
Child, Preschool | 1 | 1999 | 41006 | 0.010 |
Why?
|
Patient Dropouts | 1 | 1998 | 421 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12354 | 0.010 |
Why?
|
Marital Therapy | 1 | 1976 | 45 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 1985 | 1148 | 0.010 |
Why?
|
Forensic Psychiatry | 1 | 1977 | 200 | 0.010 |
Why?
|
Methaqualone | 1 | 1975 | 4 | 0.010 |
Why?
|
Head | 1 | 2001 | 880 | 0.010 |
Why?
|
Career Choice | 1 | 1982 | 744 | 0.010 |
Why?
|
Urologic Diseases | 1 | 1978 | 244 | 0.010 |
Why?
|
Delirium | 1 | 1987 | 1609 | 0.010 |
Why?
|
Motor Skills | 2 | 1975 | 522 | 0.010 |
Why?
|
Sex Factors | 2 | 1984 | 10397 | 0.010 |
Why?
|
Patient Advocacy | 1 | 1977 | 353 | 0.010 |
Why?
|
Personal Autonomy | 1 | 1977 | 298 | 0.010 |
Why?
|
Thyroid Diseases | 1 | 1978 | 379 | 0.010 |
Why?
|
Students, Medical | 1 | 2008 | 1862 | 0.010 |
Why?
|
Butyrylcholinesterase | 1 | 1974 | 22 | 0.010 |
Why?
|
Movement | 1 | 2001 | 1471 | 0.010 |
Why?
|
Phenothiazines | 1 | 1974 | 63 | 0.010 |
Why?
|
Marriage | 1 | 1976 | 339 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1984 | 3760 | 0.010 |
Why?
|
Mescaline | 1 | 1972 | 5 | 0.010 |
Why?
|
Tape Recording | 1 | 1973 | 76 | 0.010 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 1993 | 93 | 0.010 |
Why?
|
Prospective Studies | 2 | 2003 | 53288 | 0.010 |
Why?
|
Lysergic Acid Diethylamide | 1 | 1972 | 48 | 0.010 |
Why?
|
Equipment Design | 1 | 2001 | 3582 | 0.010 |
Why?
|
Hyperbaric Oxygenation | 1 | 1974 | 163 | 0.010 |
Why?
|
Videotape Recording | 1 | 1974 | 352 | 0.010 |
Why?
|
Social Isolation | 1 | 1976 | 365 | 0.010 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 1976 | 360 | 0.010 |
Why?
|
Hypertension | 2 | 1985 | 8480 | 0.010 |
Why?
|
Heart | 1 | 1985 | 4467 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15076 | 0.010 |
Why?
|
Informed Consent | 1 | 1977 | 995 | 0.010 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1974 | 367 | 0.010 |
Why?
|
Interpersonal Relations | 2 | 1977 | 1425 | 0.010 |
Why?
|
Cohort Studies | 2 | 2004 | 40561 | 0.010 |
Why?
|
Social Perception | 1 | 1974 | 425 | 0.010 |
Why?
|
Serum Albumin | 1 | 1974 | 676 | 0.010 |
Why?
|
Problem Solving | 1 | 1973 | 440 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1998 | 1170 | 0.010 |
Why?
|
Benzopyrans | 1 | 1970 | 64 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2001 | 2624 | 0.010 |
Why?
|
Voice | 1 | 1973 | 259 | 0.010 |
Why?
|
Social Behavior Disorders | 1 | 1969 | 97 | 0.010 |
Why?
|
Gambling | 1 | 1972 | 250 | 0.010 |
Why?
|
Electroencephalography | 1 | 1984 | 6150 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 1978 | 2046 | 0.010 |
Why?
|
Parent-Child Relations | 1 | 1973 | 747 | 0.000 |
Why?
|
Logistic Models | 1 | 2003 | 13408 | 0.000 |
Why?
|
Speech | 1 | 1973 | 540 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 2000 | 6993 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1978 | 2576 | 0.000 |
Why?
|
Primary Health Care | 1 | 2003 | 4558 | 0.000 |
Why?
|
Boston | 1 | 1980 | 9313 | 0.000 |
Why?
|
Stress, Psychological | 1 | 1981 | 4245 | 0.000 |
Why?
|
Students | 1 | 1975 | 1654 | 0.000 |
Why?
|
Heart Diseases | 1 | 1978 | 2788 | 0.000 |
Why?
|
Educational Status | 1 | 1973 | 2540 | 0.000 |
Why?
|
Retrospective Studies | 2 | 2004 | 77449 | 0.000 |
Why?
|
Parkinson Disease | 1 | 1978 | 2775 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1984 | 20129 | 0.000 |
Why?
|
Blood Pressure | 2 | 1974 | 8554 | 0.000 |
Why?
|
Pancreatic Neoplasms | 1 | 1978 | 5256 | 0.000 |
Why?
|
Life Style | 1 | 1972 | 3835 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1985 | 15165 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1970 | 7785 | 0.000 |
Why?
|
Social Adjustment | 1 | 1978 | 631 | 0.000 |
Why?
|
Vascular Resistance | 1 | 1978 | 936 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1978 | 13695 | 0.000 |
Why?
|
Vertigo | 1 | 1975 | 202 | 0.000 |
Why?
|
Ataxia | 1 | 1975 | 304 | 0.000 |
Why?
|
Disorders of Excessive Somnolence | 1 | 1975 | 271 | 0.000 |
Why?
|
Euphoria | 1 | 1970 | 67 | 0.000 |
Why?
|
Pulse | 1 | 1970 | 229 | 0.000 |
Why?
|
Choice Behavior | 1 | 1975 | 803 | 0.000 |
Why?
|
Psychology | 1 | 1970 | 356 | 0.000 |
Why?
|
Body Temperature | 1 | 1970 | 777 | 0.000 |
Why?
|
Music | 1 | 1970 | 263 | 0.000 |
Why?
|
Sexual Behavior | 1 | 1975 | 2057 | 0.000 |
Why?
|
Length of Stay | 1 | 1978 | 6309 | 0.000 |
Why?
|
Perception | 1 | 1970 | 1198 | 0.000 |
Why?
|